For the Inventor, By the Inventor

Enter inventor name

Madison, WI, United States of America

James Thoden

This inventor holds 14 USPTO granted patents and 1 EPO patent. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Thoden. Retrieved from https://idiyas.com/inventor/james-thoden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 57.1

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 63(Granted Patents)

Company Filing History:

14 out of 4,237

Wisconsin Alumni Research Foundation

Years Active: 2002-2023

Loading Chart...

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11697635 - Procedure for crystallization of (22E)-(24R)-2-methylene-22-dehydro-1α,24-25-trihydroxy-19-nor-vitamin D (2023-07-11),

2. 10494337 - (20S)-1-α,25-dihydroxy-24,24-difluoro-19-nor-vitamin Danalogs and their pharmaceutical uses (2019-12-03),

3. 9212137 - [object Object] (2015-12-15),

4. 9040728 - [object Object] (2015-05-26),

5. 8940916 - Crystallization of (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D3 (2015-01-27),

6. 8884039 - [object Object] (2014-11-11),

7. 8664206 - [object Object] (2014-03-04),

8. 8519169 - Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3 (2013-08-27),

9. 8420839 - Crystallization of 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol (2013-04-16),

10. 8404874 - [object Object] (2013-03-26),

11. 6835723 - 2-methylene-19-nor-20(S)-1&agr;-hydroxy-bis-homo-pregnacalciferol in crystalline form (2004-12-28),

12. 6462031 - Crystalline 1&agr;-hydroxyvitamin D2 and method of purification thereof (2002-10-08),

13. 6432936 - Crystalline 1&agr;-hydroxyvitamin D2 and method of purification thereof (2002-08-13),

14. 6362350 - Crystalline 1&agr;, 24(S)-dihydroxyvitamin D2 and method of purification thereof (2002-03-26),

Title: The Innovative Mind of James Thoden: Transforming Vitamin D Research

Introduction

James Thoden, an accomplished inventor based in Madison, WI, is renowned for his significant contributions to the field of vitamin D research. With an impressive portfolio of 14 patents, Thoden has established himself as a leading figure in the development of pharmaceutical compounds that hold the potential for substantial health benefits.

Latest Patents

Among his latest patents, Thoden has developed a method for the crystallization of (22E)-(24R)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D. This innovative process involves purifying the compound by dissolving it in a solvent mixture of ethyl acetate and hexane, allowing it to crystallize, and then recovering the crystals from the solution. Additionally, he has patented a series of 1α,25-dihydroxy-24,24-difluoro-19-nor-vitamin D analogs, which are valuable for their potential pharmaceutical applications.

Career Highlights

James Thoden’s career is marked by his association with the Wisconsin Alumni Research Foundation, where he has made groundbreaking advancements in the field of vitamin D analogs. His extensive research has led to innovative formulations that enhance the efficacy and application of vitamin D in medical settings.

Collaborations

Thoden has collaborated with esteemed colleagues, including Hector Floyd DeLuca and Hazel Holden, who have also contributed significantly to the field of vitamin D research. Their teamwork has fostered an environment of collaboration that promotes the sharing of ideas and accelerates innovative discoveries in this vital area of health science.

Conclusion

James Thoden's work exemplifies the intersection of innovation and science. His patents not only showcase his inventive spirit but also hold the promise of transforming vitamin D therapies. With his continuous dedication to research and development, Thoden sets a remarkable example for future inventors seeking to make impactful changes in the world of health and medicine.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…